DZ2937A1 - Compositions nouvelles de sensibilidants à l'insuline. - Google Patents

Compositions nouvelles de sensibilidants à l'insuline.

Info

Publication number
DZ2937A1
DZ2937A1 DZ990237A DZ990237A DZ2937A1 DZ 2937 A1 DZ2937 A1 DZ 2937A1 DZ 990237 A DZ990237 A DZ 990237A DZ 990237 A DZ990237 A DZ 990237A DZ 2937 A1 DZ2937 A1 DZ 2937A1
Authority
DZ
Algeria
Prior art keywords
new compositions
insulin sensitizers
sensitizers
insulin
compositions
Prior art date
Application number
DZ990237A
Other languages
English (en)
Inventor
Robert Glinecke
William Muldoon
Joseph Sauer
Susan Marie Milosovich
Vicenzo Re
Janet Louise Skinner
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824870.1A external-priority patent/GB9824870D0/en
Priority claimed from GBGB9912189.9A external-priority patent/GB9912189D0/en
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2937A1 publication Critical patent/DZ2937A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DZ990237A 1998-11-12 1999-11-10 Compositions nouvelles de sensibilidants à l'insuline. DZ2937A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9824870.1A GB9824870D0 (en) 1998-11-12 1998-11-12 Novel composition and use
GBGB9912189.9A GB9912189D0 (en) 1999-05-25 1999-05-25 Novel composition and use

Publications (1)

Publication Number Publication Date
DZ2937A1 true DZ2937A1 (fr) 2004-03-15

Family

ID=26314667

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990237A DZ2937A1 (fr) 1998-11-12 1999-11-10 Compositions nouvelles de sensibilidants à l'insuline.

Country Status (39)

Country Link
EP (3) EP1917962A1 (fr)
JP (1) JP2002529505A (fr)
KR (2) KR100732599B1 (fr)
CN (1) CN1289081C (fr)
AP (2) AP1901A (fr)
AR (2) AR023700A1 (fr)
AT (1) ATE382352T1 (fr)
AU (1) AU768578B2 (fr)
BG (2) BG65444B1 (fr)
BR (1) BR9915215A (fr)
CA (1) CA2350659C (fr)
CO (1) CO5190673A1 (fr)
CY (1) CY1107909T1 (fr)
CZ (1) CZ20011628A3 (fr)
DE (1) DE69937898T2 (fr)
DK (1) DK1128827T3 (fr)
DZ (1) DZ2937A1 (fr)
EA (3) EA200601144A1 (fr)
EG (2) EG22344A (fr)
ES (1) ES2299269T3 (fr)
HK (1) HK1040909B (fr)
HR (2) HRP20010342B1 (fr)
HU (1) HUP0104307A3 (fr)
ID (1) ID29344A (fr)
IL (2) IL143003A0 (fr)
MY (1) MY135973A (fr)
NO (1) NO20012351L (fr)
NZ (2) NZ526440A (fr)
OA (1) OA11676A (fr)
PE (1) PE20001428A1 (fr)
PL (1) PL198717B1 (fr)
PT (1) PT1128827E (fr)
RS (1) RS50208B (fr)
SI (1) SI1128827T1 (fr)
SK (1) SK286937B6 (fr)
TR (2) TR200101337T2 (fr)
TW (2) TWI246920B (fr)
UY (2) UY25798A1 (fr)
WO (1) WO2000028990A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
AR030920A1 (es) 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
JP2004504264A (ja) * 2000-01-07 2004-02-12 ユニバーシティ オブ シンシナティ Th1又はth2リンパ球に制御される免疫応答の選択的活性化
ATE380022T1 (de) * 2001-01-31 2007-12-15 Evonik Roehm Gmbh Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
AU2002367154A1 (en) * 2001-12-21 2003-07-15 Smithkline Beecham Corporation Dosing regimen for ppar-gamma activators
PE20030800A1 (es) * 2002-02-12 2003-10-31 Glaxo Group Ltd Forma de dosificacion oral de liberacion controlada
CN100367960C (zh) * 2002-07-11 2008-02-13 武田药品工业株式会社 包衣制剂的制备方法
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
WO2004062577A2 (fr) 2003-01-03 2004-07-29 Shire Laboratories Inc. Utilisation d'un melange de deux ou de plusieurs materiaux enteriques afin de reguler la liberation de medicaments via une membrane ou une matrice dans des therapies systemiques
KR101114808B1 (ko) 2003-01-29 2012-02-15 다케다 야쿠힌 고교 가부시키가이샤 피복 제제의 제조법
ES2241478B1 (es) * 2004-02-13 2006-11-16 Lacer S.A. Preparacion farmaceutica para la liberacion sostenida de un principio farmaceuticamente activo.
FI20060501L (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
CA2878866C (fr) * 2011-07-14 2021-02-23 Able Cerebral, Llc Composition, dispositif et procede pour la liberation retardee et prolongee de molecules energeniques pour le cerveau
CA2936746C (fr) 2014-10-31 2017-06-27 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
DK173350B1 (da) 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (fr) 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
US4791125A (en) 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (fr) 1988-03-08 1989-09-21 Pfizer Inc. Derives de thiaxolidinedione hypoglycemiques
WO1989008650A1 (fr) 1988-03-08 1989-09-21 Pfizer Inc. Agents hypoglycemiques de thiazolidinedione
WO1991007107A1 (fr) 1989-11-13 1991-05-30 Pfizer Inc. Agents d'oxazolidinedione hypoglycemiques
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
EP0533933A4 (en) 1990-07-03 1993-05-05 Yamanouchi Pharmaceutical Co. Ltd. Bisheterocyclic compound
AU645112B2 (en) 1990-08-23 1994-01-06 Pfizer Inc. Hypoglycemic hydroxyurea derivatives
JPH04210683A (ja) 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
SK109993A3 (en) 1991-04-11 1994-12-07 Upjohn Co Thiazolidinedione derivatives producing and use thereof
US5183823A (en) 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
TW222626B (fr) 1991-07-22 1994-04-21 Pfizer
FR2680512B1 (fr) 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH05271204A (ja) 1992-03-26 1993-10-19 Japan Tobacco Inc 新規なトリアジン誘導体
US5264451A (en) 1992-04-07 1993-11-23 American Home Products Corporation Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
WO1993021166A1 (fr) 1992-04-10 1993-10-28 Smithkline Beecham Plc Composes heterocycliques et leur utilisation pour le traitement du diabete du type ii
WO1993022445A1 (fr) 1992-05-05 1993-11-11 The Upjohn Company Procede de production de metabolites de pioglitazone
EP0648212B1 (fr) 1992-07-03 2001-10-24 Smithkline Beecham Plc Derives benzoxazole et benzothiazole comme produits pharmaceutiques
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
JP3256841B2 (ja) * 1996-06-27 2002-02-18 武田薬品工業株式会社 ベンズアルデヒド化合物の製造法
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
AU6576398A (en) * 1997-03-24 1998-10-20 Galderma Research & Development, S.N.C. Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
TWI257305B (en) 2006-07-01
AP2008004490A0 (en) 2008-06-30
SI1128827T1 (sl) 2008-06-30
HUP0104307A3 (en) 2003-12-29
PL348153A1 (en) 2002-05-06
ES2299269T3 (es) 2008-05-16
HUP0104307A2 (hu) 2002-07-29
MY135973A (en) 2008-07-31
EP1128827B1 (fr) 2008-01-02
RS50208B (sr) 2009-07-15
UY25798A1 (es) 2000-12-29
KR100732599B1 (ko) 2007-06-27
PE20001428A1 (es) 2001-02-08
BR9915215A (pt) 2001-07-31
DE69937898D1 (de) 2008-02-14
PT1128827E (pt) 2008-03-10
NZ526440A (en) 2005-01-28
PL198717B1 (pl) 2008-07-31
BG65444B1 (bg) 2008-08-29
NO20012351D0 (no) 2001-05-11
IL183972A0 (en) 2007-10-31
TR200101337T2 (tr) 2001-11-21
CA2350659C (fr) 2009-06-09
BG109893A (bg) 2008-11-28
HK1040909B (zh) 2008-08-01
WO2000028990A1 (fr) 2000-05-25
SK286937B6 (sk) 2009-07-06
KR20060097140A (ko) 2006-09-13
CN1333683A (zh) 2002-01-30
AR023700A1 (es) 2002-09-04
EG22344A (en) 2002-12-31
KR20010073229A (ko) 2001-07-31
EP1917962A1 (fr) 2008-05-07
EA200702648A1 (ru) 2008-10-30
EA007608B1 (ru) 2006-12-29
CZ20011628A3 (cs) 2001-12-12
AU768578B2 (en) 2003-12-18
JP2002529505A (ja) 2002-09-10
AU1272900A (en) 2000-06-05
NZ511611A (en) 2003-10-31
TWI246920B (en) 2006-01-11
TW200505436A (en) 2005-02-16
DK1128827T3 (da) 2008-04-28
CN1289081C (zh) 2006-12-13
OA11676A (en) 2005-01-12
DE69937898T2 (de) 2009-01-02
CO5190673A1 (es) 2002-08-29
YU36401A (sh) 2004-05-12
IL143003A0 (en) 2002-04-21
NO20012351L (no) 2001-07-04
AP1901A (en) 2008-10-24
CA2350659A1 (fr) 2000-05-25
EA200100540A1 (ru) 2001-10-22
CY1107909T1 (el) 2013-09-04
HK1040909A1 (en) 2002-06-28
HRP20010342B1 (en) 2008-04-30
HRP20010342A2 (en) 2002-06-30
ID29344A (id) 2001-08-23
EG24463A (en) 2009-07-16
EP1128827A1 (fr) 2001-09-05
EA200601144A1 (ru) 2007-02-27
BG105570A (en) 2002-02-28
SK6432001A3 (en) 2001-12-03
AR023699A1 (es) 2002-09-04
TR200503846T2 (tr) 2007-01-22
HRP20080117A2 (en) 2008-10-31
UY25800A1 (es) 2000-08-21
EP1815855A1 (fr) 2007-08-08
ATE382352T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
DE69912141D1 (de) Härtbare perfluorelastomerzusammensetzung
IS5430A (is) Ný samsetning
BR9915515B1 (pt) composiÇço curÁvel de multicomponentes.
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
PT946100E (pt) Composicoes herbicidas contendo n-¬(4,6-dimetoxipirimidin-2-il)aminocarbonil|-5-metilsulfonamidometil-2-alcoxicarbonilbenzenossulfonamidas
DZ2937A1 (fr) Compositions nouvelles de sensibilidants à l'insuline.
DE69918698D1 (de) Härtbare perfluorelastomerzusammensetzung
MA25527A1 (fr) Composition d'encollage.
ID27201A (id) Komposisi farmasi
DK1437359T3 (da) Hidtil ukendte 3,6-hemiketaler fra 9a-azalidklassen
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
DE69811331T2 (de) N-[3'-(1'-Chloro-3'-methyl-2'-oxopentan)]-3,5-dichloro-4-methylbenzamid enthaltende fungizide Zusammensetzungen
DE69926606D1 (de) Plazentaprotein 13
EE04217B1 (et) Farmatseutilised kompositsioonid
FR2783401B1 (fr) Nouvelles compositions fongicides
DE69908356D1 (de) Riechstoffe
NO20005551D0 (no) 2"-deoksyhygromycinderivater
NO20011313L (no) Ny sammensetning
DE69903532T2 (de) 4-isobutylcyclohexanol enthaltende riechstoffe
FR2775644B1 (fr) Mecanisme d'essuie-glace
DE69904800D1 (de) N-Acetonylbenzamide enthaltende fungizide Zusammensetzungen
DE69908923D1 (de) 1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen
NO996127D0 (no) 13-dihydro-3'-aziridino-antracykliner
NO20011312L (no) Ny sammensetning